Hypocalcemia Induced by Raloxifene

Author(s): Thuy D.T. Vu, Suresh Varadarajan, Ego Seeman, George Jerums, Richard J. MacIsaac

Journal Name: Current Drug Safety

Volume 7 , Issue 2 , 2012

Become EABM
Become Reviewer

Abstract:

Raloxifene is an anti-resorptive agent used in postmenopausal osteoporosis. This is the first report of the occurrence of clinically significant hypocalcemia following raloxifene treatment in a patient with occult vitamin D deficiency. Since vitamin D deficiency is widely prevalent in the community, screening for vitamin D deficiency and its correction is advisable before the initiation of anti-resorptive therapy.

Keywords: Hypocalcemia, raloxifene, vitamin D deficiency.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 7
ISSUE: 2
Year: 2012
Page: [176 - 178]
Pages: 3
DOI: 10.2174/157488612802715654
Price: $65

Article Metrics

PDF: 7